A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma
- PMID: 22919246
- PMCID: PMC3422794
- DOI: 10.3748/wjg.v18.i31.4145
A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma
Abstract
Aim: To compare the clinical outcome and pathologic features of non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) and hepatitic C virus (HCV) patients with HCC (another group in which HCC is commonly seen) undergoing liver transplantation.
Methods: Patients transplanted for HCV and NASH at our institution from January 2000 to April 2011 were analyzed. All explanted liver histology and pre-transplant liver biopsies were examined by two specialist liver histopathologists. Patient demographics, disease free survival, explant liver characteristics and HCC features (tumour number, cumulative tumour size, vascular invasion and differentiation) were compared between HCV and NASH liver transplant recipients.
Results: A total of 102 patients with NASH and 283 patients with HCV were transplanted. The incidence of HCC in NASH transplant recipients was 16.7% (17/102). The incidence of HCC in HCV transplant recipients was 22.6% (64/283). Patients with NASH-HCC were statistically older than HCV-HCC patients (P < 0.001). A significantly higher proportion of HCV-HCC patients had vascular invasion (23.4% vs 6.4%, P = 0.002) and poorly differentiated HCC (4.7% vs 0%, P < 0.001) compared to the NASH-HCC group. A trend of poorer recurrence free survival at 5 years was seen in HCV-HCC patients compared to NASH-HCC who underwent a Liver transplantation (P = 0.11).
Conclusion: Patients transplanted for NASH-HCC appear to have less aggressive tumour features compared to those with HCV-HCC, which likely in part accounts for their improved recurrence free survival.
Keywords: Comparison; Hepatitis C virus; Hepatocellular carcinoma; Liver transplant; Non-alcoholic steatohepatitis; Poorly differentiated; Recurrence; Survival; Vascular invasion.
Figures


Similar articles
-
Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis.PLoS One. 2025 Mar 19;20(3):e0317730. doi: 10.1371/journal.pone.0317730. eCollection 2025. PLoS One. 2025. PMID: 40106456 Free PMC article.
-
Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.Liver Transpl. 2017 Aug;23(8):1015-1022. doi: 10.1002/lt.24764. Epub 2017 Jun 26. Liver Transpl. 2017. PMID: 28340509
-
Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.Liver Transpl. 2016 Oct;22(10):1356-66. doi: 10.1002/lt.24507. Liver Transpl. 2016. PMID: 27348270
-
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.Ann Hepatol. 2019 Nov-Dec;18(6):855-861. doi: 10.1016/j.aohep.2019.06.014. Epub 2019 Sep 6. Ann Hepatol. 2019. PMID: 31543468
-
Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:88-92. doi: 10.1111/jgh.12239. J Gastroenterol Hepatol. 2013. PMID: 24251711 Review.
Cited by
-
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.World J Gastroenterol. 2016 Oct 7;22(37):8294-8303. doi: 10.3748/wjg.v22.i37.8294. World J Gastroenterol. 2016. PMID: 27729736 Free PMC article. Review.
-
The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma.Cancers (Basel). 2021 Jan 29;13(3):516. doi: 10.3390/cancers13030516. Cancers (Basel). 2021. PMID: 33572797 Free PMC article. Review.
-
"Weighing the risk": Obesity and outcomes following liver transplantation.World J Hepatol. 2015 Jun 18;7(11):1484-93. doi: 10.4254/wjh.v7.i11.1484. World J Hepatol. 2015. PMID: 26085908 Free PMC article. Review.
-
Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON).J Pediatr. 2016 May;172:9-13. doi: 10.1016/j.jpeds.2015.12.016. Epub 2016 Jan 1. J Pediatr. 2016. PMID: 26749112 Free PMC article. No abstract available.
-
Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis.PLoS One. 2025 Mar 19;20(3):e0317730. doi: 10.1371/journal.pone.0317730. eCollection 2025. PLoS One. 2025. PMID: 40106456 Free PMC article.
References
-
- Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549–1555. - PubMed
-
- Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43:617–649. - PubMed
-
- Ong JP, Younossi ZM. Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history? Am J Gastroenterol. 2003;98:1915–1917. - PubMed
-
- Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 2005;42:132–138. - PubMed
-
- Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol. 2003;98:2042–2047. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous